<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0"><!--This is an RSS 2.0 file. RSS stands for Really Simple Syndication.
RSS files describe news or other web content in a software-friendly way. The most
common uses of RSS files are (1) to put summaries of a "channel" on a different
website (showing a news channel's current headlines, for example) and (2) as an
aid to efficient browsing, by letting people "subscribe" to many "channels" and
see news from all of those channels efficiently. This file describes the "channel"
consisting of the web log in which you found it. For more information about RSS,
see http://backend.userland.com/rss.-->
   <channel>
      <title>FDA NEWS ALERT.com... news and blog postings from the publisher of FDA Webview and FDA Review</title>
      <link>http://www.fdanewsalert.com/index.html</link>
      <description>FDA NEWS ALERT.com... news and blog postings from the publisher of FDA Webview and FDA Review</description>
      <lastBuildDate>Wed, 23 Feb 2011 21:19:15 GMT</lastBuildDate>
      <language>en-us</language>
      <generator>Trellix SiteBuilder 6.7.8</generator>
      <docs>http://backend.userland.com/rss</docs>
      <item>
         <title>FDA Social Media Guidance Coming This Month</title>
         <link>http://www.fdanewsalert.com/2011.02.01_arch.html#1298477174357</link>
         <guid>http://www.fdanewsalert.com/2011.02.01_arch.html#1298477174357</guid>
         <pubDate>Wed, 23 Feb 2011 21:18:36 GMT</pubDate>
      </item>
      <item>
         <title>FDA's Regulatory Science Plan to Address Submission Decline</title>
         <link>http://www.fdanewsalert.com/2011.02.01_arch.html#1296591123774</link>
         <guid>http://www.fdanewsalert.com/2011.02.01_arch.html#1296591123774</guid>
         <pubDate>Tue, 01 Feb 2011 22:09:06 GMT</pubDate>
      </item>
      <item>
         <title>FDA ‘Smoke and Mirrors’ — Obama’s Inability to Change an Agency</title>
         <link>http://www.fdanewsalert.com/2010.05.01_arch.html#1273839362176</link>
         <guid>http://www.fdanewsalert.com/2010.05.01_arch.html#1273839362176</guid>
         <pubDate>Fri, 14 May 2010 12:22:50 GMT</pubDate>
      </item>
      <item>
         <title>Woodcock Sees Big Impact from ‘Comparative Effectiveness’ Unit</title>
         <link>http://www.fdanewsalert.com/2010.04.01_arch.html#1271785541967</link>
         <guid>http://www.fdanewsalert.com/2010.04.01_arch.html#1271785541967</guid>
         <pubDate>Tue, 20 Apr 2010 17:51:22 GMT</pubDate>
      </item>
      <item>
         <title>FDA Defends Use of OCI Agents in Employee ‘Conduct’ Probes</title>
         <link>http://www.fdanewsalert.com/2010.03.01_arch.html#1269623275781</link>
         <guid>http://www.fdanewsalert.com/2010.03.01_arch.html#1269623275781</guid>
         <pubDate>Fri, 26 Mar 2010 17:17:36 GMT</pubDate>
      </item>
      <item>
         <title> FDA Ad Division Shows No Slowing Down</title>
         <link>http://www.fdanewsalert.com/2010.02.01_arch.html#1265294570263</link>
         <guid>http://www.fdanewsalert.com/2010.02.01_arch.html#1265294570263</guid>
         <pubDate>Thu, 04 Feb 2010 14:47:17 GMT</pubDate>
      </item>
      <item>
         <title>Courts Struggling to Apply FDA Preemption Decision</title>
         <link>http://www.fdanewsalert.com/2010.01.01_arch.html#1264797243235</link>
         <guid>http://www.fdanewsalert.com/2010.01.01_arch.html#1264797243235</guid>
         <pubDate>Fri, 29 Jan 2010 20:44:28 GMT</pubDate>
      </item>
      <item>
         <title>Pfizer Scraps Lyrica sNDA in Reduced Pipeline</title>
         <link>http://www.fdanewsalert.com/2010.01.01_arch.html#1264627516780</link>
         <guid>http://www.fdanewsalert.com/2010.01.01_arch.html#1264627516780</guid>
         <pubDate>Thu, 28 Jan 2010 14:04:32 GMT</pubDate>
      </item>
      <item>
         <title>FDA’s Culture is Purposefully Pro-industry</title>
         <link>http://www.fdanewsalert.com/2010.01.01_arch.html#1264092805100</link>
         <guid>http://www.fdanewsalert.com/2010.01.01_arch.html#1264092805100</guid>
         <pubDate>Thu, 21 Jan 2010 17:09:05 GMT</pubDate>
      </item>
      <item>
         <title>CBER Sees False, Misleading Info in Carticel Sales Materials</title>
         <link>http://www.fdanewsalert.com/2009.10.01_arch.html#1255956960712</link>
         <guid>http://www.fdanewsalert.com/2009.10.01_arch.html#1255956960712</guid>
         <pubDate>Mon, 19 Oct 2009 13:01:48 GMT</pubDate>
      </item>
      <item>
         <title>Much More Aggressive FDA Enforcement Seen Coming</title>
         <link>http://www.fdanewsalert.com/2009.10.01_arch.html#1255617189269</link>
         <guid>http://www.fdanewsalert.com/2009.10.01_arch.html#1255617189269</guid>
         <pubDate>Thu, 15 Oct 2009 14:44:49 GMT</pubDate>
      </item>
      <item>
         <title>FDA Media Access Policy ‘Unconstitutional’ Editor Says</title>
         <link>http://www.fdanewsalert.com/2009.10.01_arch.html#1254856411537</link>
         <guid>http://www.fdanewsalert.com/2009.10.01_arch.html#1254856411537</guid>
         <pubDate>Tue, 06 Oct 2009 23:50:00 GMT</pubDate>
      </item>
      <item>
         <title>FDA Plans Second Transparency Public Meeting</title>
         <link>http://www.fdanewsalert.com/2009.10.01_arch.html#1254751842751</link>
         <guid>http://www.fdanewsalert.com/2009.10.01_arch.html#1254751842751</guid>
         <pubDate>Tue, 06 Oct 2009 23:50:32 GMT</pubDate>
      </item>
      <item>
         <title>CDRH to Re-review Menaflex Device Over ‘Compromised’ 510(k)</title>
         <link>http://www.fdanewsalert.com/2009.09.01_arch.html#1253884763693</link>
         <guid>http://www.fdanewsalert.com/2009.09.01_arch.html#1253884763693</guid>
         <pubDate>Fri, 25 Sep 2009 13:25:57 GMT</pubDate>
      </item>
      <item>
         <title>CDRH Ombudsman Denies Amalgam Dispute Resolution Bid</title>
         <link>http://www.fdanewsalert.com/2009.09.01_arch.html#1253807072649</link>
         <guid>http://www.fdanewsalert.com/2009.09.01_arch.html#1253807072649</guid>
         <pubDate>Thu, 24 Sep 2009 15:58:04 GMT</pubDate>
      </item>
      <item>
         <title>Why Drug Firms Get More Fraud Probes than Others</title>
         <link>http://www.fdanewsalert.com/2009.09.01_arch.html#1253798871690</link>
         <guid>http://www.fdanewsalert.com/2009.09.01_arch.html#1253798871690</guid>
         <pubDate>Thu, 24 Sep 2009 13:55:54 GMT</pubDate>
      </item>
      <item>
         <title>FDA Soliciting Comment on Internet, Social Media Promotion</title>
         <link>http://www.fdanewsalert.com/2009.09.01_arch.html#1253553410053</link>
         <guid>http://www.fdanewsalert.com/2009.09.01_arch.html#1253553410053</guid>
         <pubDate>Mon, 21 Sep 2009 17:40:01 GMT</pubDate>
      </item>
      <item>
         <title>Hamburg’s Daunting Mission: Raising Public Respect for FDA</title>
         <link>http://www.fdanewsalert.com/2009.09.01_arch.html#1253552436661</link>
         <guid>http://www.fdanewsalert.com/2009.09.01_arch.html#1253552436661</guid>
         <pubDate>Mon, 21 Sep 2009 17:37:56 GMT</pubDate>
      </item>
      <item>
         <title>FDA Urged to Set Comparative Effectiveness Standard</title>
         <link>http://www.fdanewsalert.com/2009.06.01_arch.html#1245069146851</link>
         <guid>http://www.fdanewsalert.com/2009.06.01_arch.html#1245069146851</guid>
         <pubDate>Tue, 16 Jun 2009 15:09:03 GMT</pubDate>
      </item>
      <item>
         <title>FTC Reiterates Follow-on Marketing Recommendations</title>
         <link>http://www.fdanewsalert.com/2009.06.01_arch.html#1245067771461</link>
         <guid>http://www.fdanewsalert.com/2009.06.01_arch.html#1245067771461</guid>
         <pubDate>Mon, 15 Jun 2009 12:17:56 GMT</pubDate>
      </item>
      <item>
         <title>Waxman Calls for Quick Follow-on Pathway Implementation</title>
         <link>http://www.fdanewsalert.com/2009.06.01_arch.html#1244550763642</link>
         <guid>http://www.fdanewsalert.com/2009.06.01_arch.html#1244550763642</guid>
         <pubDate>Tue, 09 Jun 2009 12:41:30 GMT</pubDate>
      </item>
   </channel>
</rss>
